Cargando…

Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result

Detalles Bibliográficos
Autores principales: Pitlick, Mitchell M., Park, Miguel A., Gonzalez-Estrada, Alexei, Chiarella, Sergio E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325373/
https://www.ncbi.nlm.nih.gov/pubmed/34343674
http://dx.doi.org/10.1016/j.anai.2021.07.020
_version_ 1783731547969421312
author Pitlick, Mitchell M.
Park, Miguel A.
Gonzalez-Estrada, Alexei
Chiarella, Sergio E.
author_facet Pitlick, Mitchell M.
Park, Miguel A.
Gonzalez-Estrada, Alexei
Chiarella, Sergio E.
author_sort Pitlick, Mitchell M.
collection PubMed
description
format Online
Article
Text
id pubmed-8325373
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-83253732021-08-02 Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result Pitlick, Mitchell M. Park, Miguel A. Gonzalez-Estrada, Alexei Chiarella, Sergio E. Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021-10 2021-07-31 /pmc/articles/PMC8325373/ /pubmed/34343674 http://dx.doi.org/10.1016/j.anai.2021.07.020 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters
Pitlick, Mitchell M.
Park, Miguel A.
Gonzalez-Estrada, Alexei
Chiarella, Sergio E.
Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
title Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
title_full Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
title_fullStr Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
title_full_unstemmed Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
title_short Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
title_sort biphasic anaphylaxis after first dose of messenger rna coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325373/
https://www.ncbi.nlm.nih.gov/pubmed/34343674
http://dx.doi.org/10.1016/j.anai.2021.07.020
work_keys_str_mv AT pitlickmitchellm biphasicanaphylaxisafterfirstdoseofmessengerrnacoronavirusdisease2019vaccinewithpositivepolysorbate80skintestingresult
AT parkmiguela biphasicanaphylaxisafterfirstdoseofmessengerrnacoronavirusdisease2019vaccinewithpositivepolysorbate80skintestingresult
AT gonzalezestradaalexei biphasicanaphylaxisafterfirstdoseofmessengerrnacoronavirusdisease2019vaccinewithpositivepolysorbate80skintestingresult
AT chiarellasergioe biphasicanaphylaxisafterfirstdoseofmessengerrnacoronavirusdisease2019vaccinewithpositivepolysorbate80skintestingresult